Cytokine RNA levels in transiliac bone biopsies from healthy early postmenopausal women

Bone

Volumn 26, Issue 2, 2000, Pages 137-145

  Abrahamsen, B ^a   Shalhoub, V ^a,b,c   Larson, E K ^a,b,c   Eriksen, E F ^a,b,c   Beck Nielsen, H ^a,b,c   Marks Jr , S C ^a,b,c  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Bone mineral density; Hormone replacement therapy; Interleukin 1; Menopause; Polymerase chain reaction; Postmenopausal osteoporosis

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; TRISEQUENS; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BONE ATROPHY; BONE BIOPSY; BONE MINERAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MORPHOMETRICS; MULTICENTER STUDY; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; BONE DENSITY; CYTOKINES; DNA PRIMERS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; ILIUM; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-6; LONGITUDINAL STUDIES; MENOPAUSE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; RNA, MESSENGER; SIALOGLYCOPROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033962369     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(99)00260-4     Document Type: Article

References (61)

1. Abrahamsen B., Bendtzen K., Beck-Nielsen H. Cytokines and T-lymphocyte subsets in healthy postmenopausal women estrogen retards bone loss without affecting the release of IL-1 or IL-1ra . Bone. 20:1997;251-258.
2. Abrahamsen B., Gram J., Hansen T.B., Beck-Nielsen H. Cross-calibration of QDR-2000 and QDR-1000 dual energy X-ray densitometers for bone mineral and soft tissue measurements. Bone. 16:1995;385-390.
3. Abrahamsen B., Hansen T.B., Jensen L.B., Hermann A.P., Eiken P. Site of osteodensitometry in perimenopausal women correlation and limits of agreement between anatomic regions . J Bone Miner Res. 12:1997;1471-1479.
4. Adams M.D., Dubnick M., Kerlavage A.R., Moreno R., Kelley J.M., Utterback T.R., Nagle J.W., Fields C., Venter J.C. Sequence identification of 2375 human brain genes. Nature. 355:1992;632-634.
5. Allen J.N., Herzyk D.J., Allen E.D., Wewers M.D. Human whole blood interleukin-1 beta production kinetics, cell source, and comparison with TNF-alpha . J Lab Clin Med. 119:1992;538-546.
6. Ammann P., Rizzoli R., Bonjour J.P., Bourrin S., Meyer J.M., Vassalli P., Garcia I. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J Clin Invest. 99:1997;1699-1703.
7. Arend W.P. Interleukin-1 receptor antagonist. Adv Immunol. 54:1993;167-227.
8. Bautista C.M., Mohan S., Baylink D.J. Insulin-like growth factors I and II are present in the skeletal tissues of ten vertebrates. Metabolism. 39:1990;96-100.
9. Bordier P., Matrajt H., Miravet L., Hioco D. Mesure histologique de la masse et de la résorption des travées osseuses. Pathol Microbiol. 12:1964;1238-1243.
10. Chole R.A., Faddis B.T., Tinling S.P. In vivo inhibition of localized bone resorption by human recombinant interleukin-1 receptor antagonist. J Bone Miner Res. 10:1995;281-284.
11. Chole R.A., Tinling S.P., Faddis R.T. Human recombinant interleukin-1 receptor antagonist blocks bone resorption by interleukin-1 beta but not by interleukin-1 alpha. Calcif Tissue Int. 55:1994;12-15.
12. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotech. 15:1993;532-536.
13. Cohen Solal M.E., Boitte F., Bernard Poenaru O., Denne M.A., Graulet A.M., Brazier M., De Vernejoul M.C. Increased bone resorbing activity of peripheral monocyte culture supernatants in elderly women. J Clin Endocrinol Metab. 83:1998;1687-1690.
14. Cohen Solal M.E., Graulet A.M., Denne M.A., Gueris J., Baylink D., De Vernejoul M.C. Peripheral monocyte culture supernatants of menopausal women can induce bone resorption involvement of cytokines . J Clin Endocrinol Metab. 77:1993;1648-1653.
15. Eisenberg S.P., Brewer M.T., Verdeerber E., Heimdal P., Brandhuber B.J., Thompson R.C. Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family evolution of a cytokine control mechanism . Proc Natl Acad Sci USA. 88:1991;5232-5236.
16. Ercolani L., Florence B., Denaro M., Alexander M. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem. 263:1988;15335-15341.
17. Eriksen E.F. Normal and pathological remodeling of human trabecular bone three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease . Endocrin Rev. 7:1986;379-408.
18. Eriksen E.F., Hodgson S.F., Eastell R., Cedel S.L., O'Fallon W.M., Riggs B.L. Cancellous bone remodeling in type I (postmenopausal) osteoporosis quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels . J Bone Miner Res. 5:1990;311-319.
19. Garrett I.R., Guise T.A., Bonewald L.F., Chizzonite R., Mundy G.R. Evidence that interleukin-1 mediates its effects on bone resorption via the 80 kilodalton interleukin-1 receptor. Calcif Tissue Int. 52:1993;438-441.
20. Hentunen T.A., Cunningham N.S., Vuolteenaho O., Reddi A.H., Vaananen H.K. Osteoclast recruiting activity in bone matrix. Bone Miner. 25:1994;183-198.
21. Hogasen A.K., Nordsletten L., Aasen A.O., Falch J.A. There is no difference in spontaneous and 17 beta-estradiol-induced interleukin-1 beta release by peripheral blood mononuclear cells from nonosteoporotic women with different rates of early postmenopausal bone loss. J Clin Endocrinol Metab. 80:1995;2480-2484.
22. Hustmyer F.G., Walker E., Yu X.P., Girasole G., Sakagami Y., Peacock M., Manolagas S.C. Cytokine production and surface antigen expression by peripheral blood mononuclear cells in postmenopausal osteoporosis. J Bone Miner Res. 8:1993;51-59.
23. Jilka R.L. Cytokines, bone remodelling, and estrogen deficiency a 1998 update . Bone. 23:1998;75-81.
24. Kania D.M., Binkley N., Checovich M., Havighurst T., Schilling M., Ershler W.B. Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density. J Am Geriatr Soc. 43:1995;236-239.
25. Kassem M., Harris S.A., Spelsberg T.C., Riggs B.L. Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors. J Bone Miner Res. 11:1996;193-199.
26. Kassem M., Khosla S., Spelsberg T.C., Riggs B.L. Cytokine production in the bone marrow microenvironment failure to demonstrate estrogen regulation in early postmenopausal women . J Clin Endocrinol Metab. 81:1996;513-518.
27. Khosla S., Peterson J.M., Egan K., Jones J.D., Riggs B.L. Circulating cytokine levels in osteoporotic and normal women. J Clin Endocrinol Metab. 79:1994;707-711.
28. Kimble R.B., Matayoshi A.B., Vannice J.L., Kung V.T., Williams C., Pacifici R. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology. 136:1995;3054-3061.
29. Kimble R.B., Srivastava S., Pacifici R. Estrogen inhibits macrophage TNF gene expression by modulating binding of transcription factors to the AP-1 binding site. J Bone Miner Res. 12:(Suppl. 1):1997;44.
30. Kimble R.B., Vannice J.L., Bloedow D.C., Thompson R.C., Hopfer W., Kung V.T., Brownfield C., Pacifici R. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J Clin Invest. 93:1994;1959-1967.
31. Kleinbaum, D. G., Kupper, L. L., and Muller, K. E. Comparing two straight lines using a single regression equation. In: Payne, M. Applied Regression Analysis and Other Multivariable Methods, 2nd ed. Belmont, CA: Duxbury Press; 1987; 271-273.
32. Li Z.G., Danis V.A., Brooks P.M. Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol. 11:1993;157-162.
33. Lilley J., Walters B.G., Heath D.A., Drolc Z. In vivo and in vitro precision for bone density measured by dual-energy X-ray absorption. Osteopor Int. 1:1991;141-146.
34. Malyak M., Smith M.F., Abel A.A., Arend W.P. Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta. J Clin Immunol. 14:1994;20-30.
35. March C.J., Mosley B., Larsen A., Cerretti D.P., Braedt G., Price V., Gillis S., Henney C.S., Kronheim S.R., Grabstein K., Conlon P.J., Hopp T.P., Cosman D. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature. 315:1985;641-647.
36. McKane W.R., Khosla S., Peterson J.M., Egan K., Riggs B.L. Circulating levels of cytokines that modulate bone resorption effects of age and menopause in women . J Bone Miner Res. 9:1994;1313-1318.
37. Mori H., Sawairi M., Itoh N., Hanabayashi T., Tamaya T. Effects of sex steroids on cell differentiation and interleukin-1 beta production in the human promyelocytic leukemia cell line HL-60. J Reprod Med. 37:1992;871-878.
38. Orwoll E.S., Oviatt S.K. Longitudinal precision of dual-energy x-ray absorptiometry in a multicenter study. The Nafarelin/Bone Study Group. J Bone Miner Res. 6:1991;191-197.
39. Pacifici R. Is there a causal role for IL-1 in postmenopausal bone loss? [editorial]. Calcif Tissue Int Apr. 50:1992;295-299.
40. Pacifici R., Carano A., Santoro S., Rifas L., Jeffrey J., Malone J., McCracken R., Avioli L. Bone matrix constituents stimulate interleukin-1 release from human blood mononuclear cells. J Clin Invest. 87:1991;221-228.
41. Pacifici R., Rifas L., McCracken R., Vered I., McMurtry C., Avioli L.V., Peck W.A. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA. 86:1989;2398-2402.
42. Pacifici R., Rifas L., Teitelbaum S., Slatopolsky E., McCracken R., Bergfeld M., Lee W., Avioli L.V., Peck W.A. Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc Natl Acad Sci USA. 84:1987;4616-4620.
43. Pacifici R., Vannice J.L., Rifas L., Kimble R.B. Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women effects of menopause and estrogen/progesterone therapy . J Clin Endocrinol Metab. 77:1993;1135-1141.
44. Paludan K., Thestrup Pedersen K. Use of the polymerase chain reaction in quantification of interleukin 8 mRNA in minute epidermal samples. J Invest Dermatol. 99:1992;830-835.
45. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., Ott S.M., Recker R.R. Bone histomorphometry standardization of nomenclature, symbols and units . J Bone Miner Res. 2:1987;595-610.
46. Pioli G., Basini G., Pedrazzoni M., Musetti G., Ulietti V., Bresciani D., Villa P., Bacchi A., Hughes D., Russell G., Passeri M. Spontaneous release of interleukin-1 and interleukin-6 by peripheral blood mononuclear cells after oophorectomy. Clin Sci. 83:1992;503-507.
47. Polan M.L., Daniele A., Kuo A. Gonadal steroids modulate human monocyte interleukin-1 (IL-1) activity. Fertil Steril. 49:1988;964-968.
48. Poli V., Balena R., Fattori E., Markatos A., Yamamoto M., Tanaka H., Ciliberto G., Rodan G.A., Costantini F. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. Eur Mol Biol Organ J. 13:1994;1189-1196.
49. Ralston S.H. Analysis of gene expression in human bone biopsies by polymerase chain reaction evidence for enhanced cytokine expression in postmenopausal osteoporosis . J Bone Miner Res. 9:1994;883-890.
50. Rickard D., Russell G., Gowen M. Oestradiol inhibits the release of tumour necrosis factor but not interleukin 6 from adult human osteoblasts in vitro. Osteopor Int. 2:1992;94-102.
51. Selby P., McGarrigle H.H., Peacock M. Comparison of the effects of oral and transdermal oestradiol administration on oestrogen metabolism, protein synthesis, gonadotrophin release, bone turnover and climateric symptoms in postmenopausal women. Clin Endocrinol (Oxf). 30:1989;241-249.
52. Siebert P.D., Larrick J.W. PCR MIMICS competitive DNA fragments for use as internal standards in quantitative PCR . Biotech. 14:1993;244-249.
53. Stein B., Yang M.X. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol. 15:1995;4971-4979.
54. Stock J.L., Coderre J.A., McDonald B., Rosenwasser L.J. Effects of estrogen in vivo and in vitro on spontaneous interleukin-1 release by monocytes from postmenopausal women. J Clin Endocrinol Metab. 68:1989;364-368.
55. Vannier E., Dinarello C.A. Histamine enhances interleukin (IL)-1 induced IL-1 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells. Comparison with IL-1 receptor antagonist. J Clin Invest. 92:1993;281-287.
56. Vannier E., Miller L.C., Dinarello C.A. Coordinated antiinflammatory effects of interleukin 4 interleukin 4 suppresses interleukin 1 production but upregulates gene expression and synthesis of interleukin 1 receptor antagonist . Proc Natl Acad Sci USA. 89:1992;4076-4080.
57. Vytasek R. A sensitive fluorometric assay for the determination of DNA. Anal Biochem. 120:1982;243-248.
58. Wang A.M., Doyle M.V., Mark D.F. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA. 86:1989;9717-9721.
59. Wolf K., Reske N., Blum W.F., Ziegler R., Pfeilschifter J. The concentrations of TGF-beta, IGF-1 and IGF-2 in vertebral trabecular bone matrix do not change with age (Abstr.). Calcif Tissue Int. 52:(Suppl. 1):1993;108.
60. Zarrabeita M.T., Riancho J.A., Amado J.A., Napal J., Gonzales-Marcias J. Cytokine production by peripheral blood cells in postmenopausal osteoporosis. Bone Miner. 14:1991;161-167.
61. Zheng X., Vrindts Y., De Groote D., Franchimont N., Reginster J.Y., Franchimont P. Direct stimulation of cytokines (IL-1 beta, IL-2, IL-6, TNF-alpha, IFN-gamma, GM-CSF, LIF) in whole blood. Differences between normal and osteoporotic postmenopausal women. J Bone Miner Res. 9:(Suppl.):1994;322-371.